For Lisa McDevitt, there's nothing better than hitting the road in her limited-edition "Warriors In Pink" mustang.
“I actually had a woman follow me home, and she wanted to know how much, and I was like it's not for sale,” explained McDevitt, a cervical cancer patient.
It's Lisa's reward for successfully battling and beating cervical cancer twice. Her doctor at the time said she wouldn't survive round two.
"She said you will be dead within six years,” she said. “I really was just ready to die."
That's when Dr. Larry Kilgore asked her to join a clinical trial. It's for patients with advanced or recurrent cervical cancer. Researchers are testing a new therapy that combines the drug Avastin with chemo.
"So, the chemotherapy kills the cancer cells, and the biologic agent stops blood vessel growth, so tumors can't grow,” explains Dr. Kilgore. “It's a real, real advance."
As for Lisa, it's been two years since her last chemo.
"Yes, she is disease-free. We will have to follow her to see, but so far, so good," said Dr. Kilgore.
Results from the phase 3 trial showed patients who received Avastin and chemo lived an average of 17 months compared to just 13 months for those treated with chemo alone.